You are here: Industry Insights > Tumor

News List

Routine HPV Testing May Be Warranted for Sinonasal Cancers drugs
January 06, 2020
Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online December in Cancer.
New Workflow Could Improve Imaging Assessment in Research drugs
January 03, 2020
Institutional imaging cores may help provide unbiased and reproducible measurements and enable a leaner workflow in assessing tumor measurements for patients participating in clinical trials ...
Researchers determine how a specific protein regulates tumor growth worldpharmanews
January 03, 2020
Immune checkpoints are surface proteins that cancer cells use to evade immune response. These surface proteins are critical for cancer cell growth and drugs targeting these proteins have ...
Researchers identify immune-suppressing target in glioblastoma worldpharmanews
December 24, 2019
Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma with ...
Retrogenix and Resonant Therapeutics announce strategic alliance to identify targets of anti-tumour antibodies pharmaceutical-business-review
December 16, 2019
UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced that they have entered into a non-exclusive strategic partnership to ...
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors En-CPhI.CN
December 10, 2019
BJ Bioscience Inc. announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY in San Antonio, Texas.
BioLineRx Doses First Patient in Solid Tumor Immunotherapy Study americanpharmaceuticalreview
September 27, 2019
BioLineRx announced dosing of the first patient in part 2 of the Phase 1/2a clinical study for AGI-134, a novel compound that evokes a direct anti-tumor response, as well as a vaccine effect, via a unique ...
CAR T for Large Tumors: The Next Frontier? contractpharma
September 12, 2019
Traditional cancer treatments tend to be unprecise, the effect of which both healthy and cancerous cells are destroyed. Chemotherapy or radiation are like the military carpet bombing an area...
Infinity Announces Start of Two IPI-549 Trials for Solid Tumors americanpharmaceuticalreview
September 05, 2019
Infinity Pharmaceuticals announced the initiation of two clinical trials for IPI-549, a first-in-class, oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through ...
BioLineRx Successfully Completes Dose-Escalation Part for AGI-134 Study americanpharmaceuticalreview
September 04, 2019
BioLineRx has successfully completed the dose-escalation part of the Phase 1/2a clinical study for AGI-134, a novel compound that evokes a direct anti-tumor response, as well as a vaccine effect...

Previous page 1 2 3 4 5 6 7 Next page